Physician profile
Kelsey Smith
NPI 1417401720
$3,169.15
in general payments reported to CMS, 2019-2025
20 companies · $963 in 2025
The $963 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.13 · 2022: $355 · 2023: $706 · 2024: $1,074 · 2025: $963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,176 · Education: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,176.14 |
| Education | $566.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,241.56 | 2021-2025 | Krystexxa, Otezla, Enbrel |
| Janssen Biotech, INC. | $552.97 | 2021-2025 | Tremfya, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $300.83 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $287.72 | 2024-2025 | Acthar |
| Horizon Therapeutics Plc | $186.11 | 2023 | Krystexxa |
| Abbvie INC. | $111.47 | 2023-2025 | |
| Ucb, INC. | $98.95 | 2024-2025 | Bimzelx |
| Sanofi-Aventis U.S. LLC | $88.60 | 2023 | |
| Glaxosmithkline, LLC. | $44.14 | 2025 | Benlysta |
| Alexion Pharmaceuticals, INC. | $43.81 | 2023-2025 | Strensiq |
| Kyowa Kirin, INC. | $36.92 | 2024 | Crysvita |
| E.R. Squibb & Sons, L.L.C. | $23.69 | 2024 | Orencia |
| Janssen Pharmaceuticals, INC | $22.91 | 2025 | Tremfya |
| Bioventus LLC | $21.33 | 2025 | Durolane |
| Abiomed | $20.04 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $19.90 | 2025 | Purified Cortrophin Gel |
| Sobi, INC | $19.25 | 2024 | |
| Lilly USA, LLC | $19.17 | 2024 | Taltz |
| Pfizer INC. | $14.91 | 2023 | |
| Aurinia Pharma U.S., INC. | $14.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.